Advertisement

Topics

Pharma executives weigh in on possible changes under Trump

13:35 EST 1 Dec 2016 | Reuters

NEW YORK (Reuters) - Top executives from large U.S. drugmakers on Thursday discussed for the first time possible changes for the industry under President-elect Donald Trump, and issues that have damaged the reputation of their industry.

Original Article: Pharma executives weigh in on possible changes under Trump

NEXT ARTICLE

More From BioPortfolio on "Pharma executives weigh in on possible changes under Trump"

Quick Search
Advertisement